What is he best known for?
The fields of study he is best known for:
The scientist’s investigation covers issues in Genetics, Cell biology, Cancer research, Gene expression profiling and Cancer.
His Genetics and Deep sequencing, Gene regulatory network, Genomics, Gene and DNA sequencing investigations all form part of his Genetics research activities.
His Cell biology research includes themes of Apoptosis, Cell, Receptor and Cell culture.
His study in Gene expression profiling is interdisciplinary in nature, drawing from both Cell type, Microarray, DNA microarray, Human brain and Computational biology.
Roland Eils has researched Cancer in several fields, including Germline mutation, Comparative genomic hybridization and Human genetics.
His Human genetics research integrates issues from Medulloblastoma, Genome, Human genome and Bioinformatics.
His most cited work include:
- Signatures of mutational processes in human cancer (5372 citations)
- International network of cancer genome projects (1611 citations)
- International network of cancer genome projects (1611 citations)
What are the main themes of his work throughout his whole career to date?
Computational biology, Genetics, Cell biology, Gene and Artificial intelligence are his primary areas of study.
His work carried out in the field of Computational biology brings together such families of science as Cas9, CRISPR, Bioinformatics, Genomics and DNA microarray.
His work in Genome, Cancer, Whole genome sequencing, Transcriptome and Chromosome is related to Genetics.
His Cell biology research includes elements of Chromatin, Cell, Receptor and Apoptosis.
He focuses mostly in the field of Gene, narrowing it down to matters related to Cancer research and, in some cases, Downregulation and upregulation and Mutation.
His work in Artificial intelligence covers topics such as Microscopy which are related to areas like Fluorescence microscope.
He most often published in these fields:
- Computational biology (26.47%)
- Genetics (25.10%)
- Cell biology (25.38%)
What were the highlights of his more recent work (between 2018-2021)?
- Gene (26.34%)
- Computational biology (26.47%)
- Cell biology (25.38%)
In recent papers he was focusing on the following fields of study:
His primary scientific interests are in Gene, Computational biology, Cell biology, Genome and Cancer research.
His Gene research entails a greater understanding of Genetics.
His Computational biology study incorporates themes from CRISPR and Robustness.
Roland Eils combines subjects such as Cell and Gene expression profiling with his study of Cell biology.
As a member of one scientific family, Roland Eils mostly works in the field of Genome, focusing on Cancer and, on occasion, Mutation and Virology.
His research integrates issues of In vitro and Downregulation and upregulation in his study of Cancer research.
Between 2018 and 2021, his most popular works were:
- Pan-cancer analysis of whole genomes (538 citations)
- SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells. (401 citations)
- SARS-CoV-2 receptor ACE2 and TMPRSS2 are primarily expressed in bronchial transient secretory cells. (401 citations)
In his most recent research, the most cited papers focused on:
Roland Eils spends much of his time researching Gene, Whole genome sequencing, Immunology, Cell biology and Genome.
His Whole genome sequencing study improves the overall literature in Genetics.
In the subject of general Immunology, his work in Immune system, Germinal center, MHC class II and T cell is often linked to European union, thereby combining diverse domains of study.
His study looks at the intersection of Cell biology and topics like Pathogenesis with Single-cell analysis, GTPase and RNA.
His work deals with themes such as Cancer and Transcriptome, which intersect with Genome.
His research in Cancer intersects with topics in Virology, APOBEC, Endogenous retrovirus, Virus Integration and Hepatitis B virus.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
